MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH)
MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name:
Read more